Tougas, Gervais
Novartis (Switzerland)
2 papers on CoChat
Most cited papers
- Verified
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut
Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis
Cited by 1,547
- Verified
Omeprazole produces parietal cell hypertrophy and hyperplasia in humans
Driman, D. K., Wright, C., Tougas, G., & Riddell, R. H. (1996) · Digestive Diseases and Sciences
Gastroesophageal reflux and treatmentsHelicobacter pylori-related gastroenterology studies
Cited by 96
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free